Press release
Oral Transmucosal Drugs Market Analysis, Size, Share and Industry report 2023-2030
Oral Transmucosal Drugs Market - DataM Intelligence
The global oral transmucosal drugs market reached USD 15,005.2 million in 2022 and is projected to witness lucrative growth by reaching up to USD 24,441.4 million by 2030. The market is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030).
Oraltransmucosal drug administration was an alternative route in end-of-life care and palliative care during the COVID-19 pandemic. Oral transmucosal drug delivery is the systemic distribution of drugs through the mucous membrane of the oral cavity. It is a preferred approach in palliative care compared to other transmucosal drug delivery since it is practical and easy to use. Oral transmucosal drug delivery is a different method for delivering dose formulations for oral or nasal administration.
The increase in incidence of autoimmune disorders, cancer cases, and respiratory issues, technological advancements, and the rise in research activities by the key players about novel oral transmucosal drugs drive the global oral transmucosal drugs market growth.
For More Insights request free sample: https://www.datamintelligence.com/download-sample/oral-transmucosal-drugs-market
Market Dynamics
Increase in the incidence of autoimmune disorders and, cancer to boost the market growth.
Due to the rise in autoimmune illnesses and cancer, the global market for oral transmucosal drugs is likely to grow during the forecast period. Oral cancer and autoimmune illnesses are all diseases that are affecting more and more people worldwide. This increases demand for oral transmucosal medications as they can prevent gastrointestinal degradation and have an immediate start of action.
For instance, according to the CDC's National Diabetes Statistics Report, there are expected to be 37.3 million cases of diabetes worldwide in 2022. About 11.3% of Americans, or 37.3 million people, have diabetes. The 28.5% of the population, or an estimated 28.7 million people, had diabetes, due to which, the demand for transmucosal medications also increases.
Regulatory challenges for the transmucosal drugwill hamperthe globaloral transmucosal drugs marketgrowth.
Regulatory challenges are one of the major factors that can impact the development and commercialization of transmucosal drugs. Some of the regulatory challenges faced by transmucosal drugs include: like all pharmaceutical products, transmucosal drugs must undergo rigorous safety and efficacy testing to gain regulatory approval.
View Full report: https://www.datamintelligence.com/research-report/oral-transmucosal-drugs-market
Market Segments
By Product Type
• Tablets
• Films
• Liquids & Spray
• Others
By Indication
• Opioid Dependence
• Neurological Disorders
• Erectile Dysfunction
• Nausea and Vomiting
By Route of Administration
• Sublingual Mucosa
• Buccal Mucosa
• By Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
Market Key Players
Major players are Pfizer Inc., ZIM Laboratories Limited, Aquestive Therapeutics, Inc, IntelGenx Corp, Indivior PLC, C.L.Pharm Co., Ltd, Seoul Pharmaceuticals, Shilpa Therapeutics, Sunovion Pharmaceuticals, Inc, and CURE Pharmaceutical, among others.
Trending Reports
Propionic Acidemia Drugs Market - https://www.datamintelligence.com/research-report/propionic-acidemia-drugs-market
Opioid Use Disorder Drugs Market - https://www.datamintelligence.com/research-report/opioid-use-disorder-drugs-market
Anti-Obesity Drugs Market - https://www.datamintelligence.com/research-report/anti-obesity-drugs-market
OTC Topical Drugs Market - https://www.datamintelligence.com/research-report/otc-topical-drugs-market
Antifibrinolytic Drugs Market - https://www.datamintelligence.com/research-report/antifibrinolytic-drugs-market
Contact Us:
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oral Transmucosal Drugs Market Analysis, Size, Share and Industry report 2023-2030 here
News-ID: 3260247 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth:
The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).
The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth:
The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth:
The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033.
The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth:
The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.
The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
